Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario. | Curr Oncol | 2021 | 34898565 | PubTator, text mining | PubMed |
| How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen. | Curr Oncol | 2021 | 34898558 | PubTator, text mining | PubMed |
| Frontline treatment in CLL: the case for time-limited treatment. | Hematology Am Soc Hematol Educ Program | 2021 | 34889444 | PubTator, text mining | PubMed |
| Integration of Mutational Signature Analysis with 3D Chromatin Data Unveils Differential AID-Related Mutagenesis in Indolent Lymphomas. | Int J Mol Sci | 2021 | 34884820 | PubTator, text mining | PubMed |
| Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies. | Hemasphere | 2021 | 34881358 | PubTator, text mining | PubMed |
| O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers. | Front Immunol | 2021 | 34868034 | PubTator, text mining | PubMed |
| Small but Mighty-The Emerging Role of snoRNAs in Hematological Malignancies. | Noncoding RNA | 2021 | 34842767 | PubTator, text mining | PubMed |
| A Systematic Review of the Sex and Gender Reporting in COVID-19 Clinical Trials. | Vaccines (Basel) | 2021 | 34835253 | PubTator, text mining | PubMed |
| Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. | Cancers (Basel) | 2021 | 34830959 | PubTator, text mining | PubMed |
| Targeted Therapies in Cancer: To Be or Not to Be, Selective. | Biomedicines | 2021 | 34829820 | PubTator, text mining | PubMed |
| Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL). | Diagnostics (Basel) | 2021 | 34829391 | PubTator, text mining | PubMed |
Angiogenic factors could help us to define patients obtaining complete response with undetectable minimal residual disease in untreated CLL patients treated by FCR: results from the CLL2010FMP, a FILO study. | Leuk Lymphoma | 2021 | 34806520 | PubTator, text mining | PubMed |
| CRIS: complete reconstruction of immunoglobulin V-D-J sequences from RNA-seq data. | Bioinform Adv | 2021 | 34806017 | PubTator, text mining | PubMed |
| Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin. | Front Oncol | 2021 | 34804974 | PubTator, text mining | PubMed |
| [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 34788923 | PubTator, text mining | PubMed |
| Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. | Cell Death Dis | 2021 | 34782617 | PubTator, text mining | PubMed |
| CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target. | Front Oncol | 2021 | 34778050 | PubTator, text mining | PubMed |
| Editorial: Mouse Models of B Cell Malignancies. | Front Immunol | 2021 | 34777400 | PubTator, text mining | PubMed |
| The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A. | Cancers (Basel) | 2021 | 34771618 | PubTator, text mining | PubMed |
| Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2021 | 34771616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=39